FrancophonIA/ELRC3.0 huggingface dataset:
English: Common (affects between 1 and 10 in 100 patients):
Slovenian: Pogosti (pojavijo se pri 1 do 10 od 100 bolnikov):
English: • If you have any further questions, ask your doctor or pharmacist.
Slovenian: • Če imate dodatna vprašanja, se posvetujte s svojim zdravnikom ali farmacevtom.
English: How to store <Aminocaproic acid-containing medicinal products> Contents of the pack and other information
Slovenian: Shranjevanje zdravil <zdravila, ki vsebujejo aminokaprojsko kislino> Vsebina pakiranja in dodatne informacije
English: For intravenous administration: 100 mg/kg or 3 g/m2 by slow intravenous infusion during the first hour, followed by continuous infusion at the rate of 33.3 mg/kg per hour or 1 g/m2 per hour.
Slovenian: Za intravensko dajanje: 100 mg/kg ali 3 g/m2 v obliki počasne intravenske infuzije prvo uro, ki ji sledi neprekinjena infuzija s hitrostjo 33,3 mg/kg na uro ali 1 g/m2 na uro.
English: [See Annex I - To be completed nationally] This leaflet was last revised in <{MM/YYYY}> <{month YYYY}>.
Slovenian: Navodilo je bilo nazadnje revidirano dne <{MM/LLLL}> <{mesec LLLL}.> [Izpolni država članica]
English: [If applicable:] <For oral administration: 100 mg/kg or 3 g/m2 during the first hour, then 33.3 mg/kg per hour or 1 g/m2 per hour (maximum 18 g/m2 (600 mg/kg) in 24 hours)>
Slovenian: [če je smiselno:] <Za peroralno dajanje: 100 mg/kg ali 3 g/m2 prvo uro, nato pa 33,3 mg/kg na uro ali 1 g/m2 na uro (največ 18 g/m2 (600 mg/kg) v 24 urah)>
English: • delirium
Slovenian: • delirij
English: • stroke
Slovenian: • driska
English: Thrombogenic effect
Slovenian: Trombogeni učinek
English: Posology [If applicable] <Aminocaproic acid-containing medicinal products> can be administered either orally or intravenously.>
Slovenian: Zdravila <Zdravila, ki vsebujejo aminokaprojsko kislino> se lahko uporabijo bodisi peroralno ali intravensko.>
English: For intravenous administration: an initial dose of 4 to 5 g will be administered by slow intravenous infusion (one hour) followed by a continuous infusion of 1 g per hour.
Slovenian: Za intravensko dajanje: začetni odmerek 4 do 5 g se da v obliki počasne intravenske infuzije (enourne), nato pa sledi neprekinjena infuzija 1 g na uro.
English: If you have any further questions, ask your doctor or pharmacist.
Slovenian: Če imate dodatna vprašanja, se posvetujte s svojim zdravnikom ali farmacevtom.
English: [If applicable] <Oral route: 100 mg/kg or 3 g/m2 during the first hour, then 33.3 mg/kg per hour or 1 g/m2 per hour (maximum 18 g/m2 (600 mg/kg) in 24 hours)>
Slovenian: [če je smiselno] <Peroralni način uporabe: 100 mg/kg ali 3 g/m2 prvo uro, nato pa 33,3 mg/kg na uro ali 1 g/m2 na uro (največ 18 g/m2 (600 mg/kg) v 24 urah)>
English: In fact, the appearance or persistence of a haemorrhage could be, and in many cases is, due to local hyperfibrinolysis, especially when the haemorrhage is in organs rich in plasminogen activators, such as the uterus, prostate, lung, urinary tract, etc. On the other hand, aminocaproic acid has been shown to have a beneficial effect on general haemorrhages, such as those of a haematological origin, in which no hyperfibrinolysis is found in circulating blood.
Slovenian: Dejansko bi lahko bil - in v mnogih primerih je - pojav ali vztrajanje krvavitve posledica lokalne hiperfibrinolize, zlasti pri krvavitvi v organih, bogatih z aktivatorji plazminogena, kot so maternica, prostata, pljuča, sečila itd.
English: • oedema (swelling),
Slovenian: • edem (oteklina)
English: Rare (affects between 1 and 10 in 10,000 patients): • pain in the arms, legs or lower back, especially pain in the calves or heels upon exertion,
Slovenian: • bolečine v rokah, nogah ali spodnjem delu hrbta, zlasti bolečina v mečih ali petah po naporu
English: • If you get any side effects talk to your doctor or pharmacist.
Slovenian: • Če opazite kateri koli neželeni učinek, se posvetujte s svojim zdravnikom ali farmacevtom.
English: Clinical presentation can range from mild myalgia with weakness and fatigue to severe proximal myopathy with rhabdomyolysis, myoglobinuria and acute renal failure Muscle enzymes, especially creatine phosphokinase (CPK), are elevated.
Slovenian: Klinična slika lahko obsega znake od blage mialgije s šibkostjo in utrujenostjo do hude proksimalne miopatije z rabdomiolizo, mioglobinurijo in akutno ledvično odpovedjo.
English: If you forget to use <Aminocaproic acid-containing medicinal products>
Slovenian: Če ste pozabili vzeti <zdravila, ki vsebujejo aminokaprojsko kislino>
English: • itching of the skin,
Slovenian: • srbenje kože
English: MARKETING AUTHORISATION NUMBER(S) [To be completed nationally]
Slovenian: ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET Z ZDRAVILOM [Izpolni država članica]
English: Reduced vision, watery eyes
Slovenian: • poslabšan vid, solzne oči
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION [To be completed nationally]
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM [Izpolni država članica]
English: Uncommon (affects between 1 and 100 in 1,000 patients):
Slovenian: Občasni (pojavijo se pri 1 do 100 od 1.000 bolnikov):
English: Abdominal pain, diarrhoea, nausea, vomiting
Slovenian: Bolezni prebavil bolečine v trebuhu, driska, navzea, bruhanje
English: Do not use <Aminocaproic acid-containing medicinal products>
Slovenian: Ne uporabljajte zdravila <zdravil, ki vsebujejo aminokaprojsko kislino>
English: Always take <Aminocaproic acid-containing medicinal products> exactly as your doctor has told you.
Slovenian: Pri uporabi zdravil <zdravila, ki vsebujejo aminokaprojsko kislino> vedno natančno upoštevajte zdravnikova navodila.
English: How to take <Aminocaproic acid-containing medicinal products> Possible side effects
Slovenian: Kako uporabljati zdravila <zdravila, ki vsebujejo aminokaprojsko kislino> Možni neželeni učinki
English: NAME OF THE MEDICINAL PRODUCT <Aminocaproic acid containing medicinal products> [See Annex I - To be completed nationally]
Slovenian: IME ZDRAVILA <Zdravila, ki vsebujejo aminokaprojsko kislino> [Glejte Prilogo I - Izpolni država članica]
English: b. Tabulated list of adverse reactions
Slovenian: b. Neželeni učinki v obliki preglednice
English: <Aminocaproic acid containing medicinal products>
Slovenian: <Zdravila, ki vsebujejo aminokaprojsko kislino>
English: vomiting, dizziness, pins and needles, loss of concentration
Slovenian: zbadanje in mrtvičenje, izgubo koncentracije
English: If in doubt, see your doctor or pharmacist.
Slovenian: Če ste negotovi, se posvetujte z zdravnikom ali farmacevtom.
English: Headache, malaise; injection site reactions, pain and necrosis
Slovenian: Splošne težave in spremembe na mestu aplikacije glavobol, splošno slabo počutje; reakcije, bolečine in nekroza na mestu injiciranja edem
English: <Aminocaproic acid-containing medicinal products> is not recommended during pregnancy..
Slovenian: Uporaba zdravila <Zdravil, ki vsebujejo aminokaprojsko kislino> med nosečnostjo ni priporočljiva.
English: • discomfort
Slovenian: • nelagodje
English: 6.6 Special precautions for disposal <and other handling> [To be completed nationally]
Slovenian: 6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom [Izpolni država članica]
English: HOW TO USE <Aminocaproic acid-containing medicinal products>
Slovenian: KAKO UPORABLJATI ZDRAVILA <zdravila, ki vsebujejo aminokaprojsko kislino>
English: Hypotension Bradycardia
Slovenian: Srčne bolezni hipotenzija bradikardija periferna ishemija tromboza
English: What <Aminocaproic acid containing medicinal product> looks like and contents of the pack [To be completed nationally]
Slovenian: Izgled zdravila <zdravilo, ki vsebuje aminokaprojsko kislino> in vsebina pakiranja [Izpolni država članica]
English: Blood and lymphatic system disorders
Slovenian: Bolezni krvi in limfatičnega sistema agranulocitoza, motnje strjevanja krvi levkopenija, trombocitopenija
English: Overdose
Slovenian: Dojenje
English: However, the following doses have been used in patients aged less than 18 years: Intravenous route: 100 mg/kg or 3 g/m2 by slow intravenous infusion during the first hour, followed by continuous infusion at the rate of 33.3 mg/kg per hour or 1 g/m2 per hour.
Slovenian: Intravenski način uporabe: 100 mg/kg ali 3 g/m2 v obliki počasne intravenske infuzije prvo uro, ki ji je sledila kontinuirana infuzija s hitrostjo 33,3 mg/kg na uro ali 1 g/m2 na uro.
English: • chest pain or chest tightness
Slovenian: • bolečine ali stiskanje v prsnem košu
English: Skin and subcutaneous tissue disorders
Slovenian: Bolezni kože in podkožja pruritus, izpuščaj
English: Necrotic alterations to the heart and liver were found in the post-mortem examination.
Slovenian: Obdukcija je razkrila nekrotične spremembe srca in jeter.
English: SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET
Slovenian: POVZETEK GLAVNIH ZNAČILNOSTI ZDRAVILA IN NAVODILO ZA UPORABO
English: • dry ejaculation.
Slovenian: • Navodilo shranite.
English: • sudden wheeziness
Slovenian: • suha ejakulacija
English: Reproductive system and breast disorders
Slovenian: Motnje reprodukcije in dojk suha ejakulacija
English: Acute myopathy, rhabdomyolysis
Slovenian: Bolezni imunskega sistema alergijske in anafilaktoidne reakcije, anafilaksa makulopapularni eritem
English: How to store <Aminocaproic acid containing medicinal product> [To be completed nationally]
Slovenian: Shranjevanje zdravila <zdravilo, ki vsebuje aminokaprojsko kislino> [Izpolni država članica]
English: Some cases of acute overdose have been described after the intravenous administration of aminocaproic acid.
Slovenian: Po intravenski uporabi aminokaprojske kisline so poročali o nekaterih primerih akutnega prevelikega odmerjanja.
English: 6.1 List of excipients [To be completed nationally]
Slovenian: FARMACEVTSKI PODATKI 6.1.Seznam pomožnih snovi [Izpolni država članica]
English: Ear and labyrinth disorders
Slovenian: Ušesne bolezni, vključno z motnjami labirinta tinitus
English: BUN increased, Nephritic colics and kidney function disorders
Slovenian: Bolezni sečil odpoved ledvic, zvišanje vrednosti BUN, ledvične kolike in motnje delovanja ledvic
English: Dizziness
Slovenian: • izpuščaj
English: Elevated CPK, myositis
Slovenian: Bolezni mišičnoskeletnega sistema in vezivnega tkiva mišična oslabelost, mialgija zvišane ravni CPK, miozitis akutna miopatija, rabdomioliza
English: <Aminocaproic acid-containing medicinal products> [If applicable] < can be administered [either orally or] intravenously, and> is indicated for the treatment and prevention of blood loss due to excessive bleeding in the following cases:
Slovenian: je indicirano za zdravljenje in preprečevanje izgube krvi zaradi močne krvavitve v naslednjih primerih:
English: BEFORE YOU USE <Aminocaproic acid-containing medicinal products>
Slovenian: KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO <zdravila, ki vsebujejo aminokaprojsko kislino>
English: What <Aminocaproic acid containing medicinal product> contains [To be completed nationally]
Slovenian: Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo <zdravilo, ki vsebuje aminokaprojsko kislino> [Izpolni država članica]
English: 6.3 Shelf life [To be completed nationally]
Slovenian: 6.3 Rok uporabnosti [Izpolni država članica]
English: Bottle (HDPE) 90 (3 x 30) tablets
Slovenian: Plastenka (HDPE) 90 (3 x 30) tablet
English: Bottle (HDPE) 30 tablets
Slovenian: Plastenka (HDPE) 30 tablet
English: Pharmaceutical form
Slovenian: Farmacevtska oblika Pot uporabe
English: Immediate packaging
Slovenian: Stična ovojnina Velikost pakiranja
English: See also Section 12.
Slovenian: Glejte tudi poglavje 12.
English: 5 days
Slovenian: 5 dni
English: The stopper should not be punctured more than 20 times.
Slovenian: Zamaška ni dovoljeno prebosti več kot 20-krat.
English: Avoid introduction of contamination during use.
Slovenian: Preprečite vnos kontaminacije med uporabo.
English: The excipients listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Slovenian: Pomožne snovi, navedene v poglavju 6.1 SPC so bodisi dovoljene snovi, za katere tabela 1 priloge Uredbe Komisije (EU) št. 37/2010 določa, da MRL ni potreben ali pa, ne spadajo v področje uporabe uredbe (ES) št. 470/2009, kadar so uporabljene tako kot v tem zdravilu za uporabo v veterinarski medicini.
English: Not authorised for use in horses producing milk for human consumption.
Slovenian: Ni dovoljena uporaba pri konjih, katerih mleko je namenjeno prehrani ljudi.
English: The active substance in Meloxidolor is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Slovenian: Učinkovina v zdravilu Meloxidolor je dovoljena učinkovina, kot je navedena v tabeli 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št. 37/2010:
English: E-mail: info@levetpharma.com
Slovenian: E-pošta: info@levetpharma.com
English: Date of first authorisation: 22/04/2013 Date of last renewal: 20/04/2018
Slovenian: Datum zadnjega podaljšanja dovoljenja za promet: 20/04/2018
English: Particular care should be taken with regard to the accuracy of dosing including the use of an appropriate dosing device and careful estimation of body weight.
Slovenian: Posebno pozornost je treba nameniti natančnemu odmerjanju, vključno z uporabo primernega pripomočka za odmerjanje in natančne ocene telesne mase.
English: Clear yellow solution.
Slovenian: Bistra rumena raztopina.
English: The main pathway of meloxicam biotransformation is oxidation.
Slovenian: Glavna pot biološke transformacije meloksikama je oksidacija.
English: 15 μg/kg Milk
Slovenian: 15 µg/kg mleko
English: The treatment-free period, however, should take into account the pharmacological properties of the products used previously.
Slovenian: Pri določanju obdobja brez zdravljenja je treba upoštevati tudi farmakološke lastnosti zdravil, ki smo jih dajali predhodno.
English: Do not use in horses less than 6 weeks of age.
Slovenian: Ne uporabite pri konjih, mlajših od 6 tednov.
English: Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Slovenian: Druga nesteroidna protivnetna zdravila, diuretiki, antikoagulansi, aminoglikozidni antibiotiki in snovi z veliko vezavo na beljakovine se lahko kompetitivno vežejo, kar lahko povzroči toksične učinke.
English: Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06
Slovenian: Farmakoterapevtska skupina: Nesteroidna protivnetna in protirevmatična zdravila (oksikami) Oznaka ATCvet: QM01AC06.
English: For dogs and cats:
Slovenian: Za pse in mačke:
English: Meloxidolor alone will not provide adequate pain relief during the dehorning procedure.
Slovenian: Samo zdravilo Meloxidolor ne zagotavlja ustreznega lajšanja bolečine med postopkom odstranjevanja rogov.
English: For cattle and pigs:
Slovenian: Za govedo in prašiče:
English: Excipient: Ethanol
Slovenian: Pomožna snov: Etanol
English: In cats, the detection of metabolites from the parent compound in urine and faeces, but not in plasma is indicative for their rapid excretion.
Slovenian: Pri mačkah prisotnost presnovkov matične spojine v urinu in blatu, ne pa v plazmi, kaže na hitro izločanje.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Slovenian: Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (neželeni učinki se pokažejo pri več kot 1 od 10 zdravljenih živali) - pogosti (pri več kot 1, toda manj kot 10 živali od 100 zdravljenih živali) - občasni (pri več kot 1, toda manj kot 10 živali od 1.000 zdravljenih živali) - redki (pri več kot 1, toda manj kot 10 živali od 10.000 zdravljenih živali) - zelo redki (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri).
English: Cats: SC
Slovenian: Mačke: s.c.
English: In dogs and cats, Meloxicam is eliminated with a half-life of 24 hours.
Slovenian: Pri psih in mačkah je razpolovna doba izločanja meloksikama 24 ur.
English: In cattle and pigs, the highest meloxicam concentrations are to be found in liver and kidney.
Slovenian: Pri govedu in prašičih je koncentracija meloksikama največja v jetrih in ledvicah.
English: Only a slight transient swelling at the injection site following subcutaneous administration was observed in less than 10 % of the cattle treated in clinical studies.
Slovenian: Opazili so le rahlo, prehodno oteklino na mestu injiciranja po subkutanem dajanju pri manj kot 10 % goveda, zdravljenega v okviru kliničnih študij.
English: For the treatment of diarrhoea in cattle, do not use in animals of less than one week of age.
Slovenian: Pri zdravljenju driske pri govedu ne uporabite pri živalih, mlajših od enega tedna.
English: For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritisagalactia syndrome) with appropriate antibiotic therapy.
Slovenian: Za pomožno zdravljenje pri zdravljenju puerperalne septikemije in toksemije (sindroma mastitisa, metritisa in agalaktije) ob ustreznem antibiotičnem zdravljenju.
English: Do not use after the expiry date stated on the label after EXP. Shelf-life after first opening the container:28 days.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na nalepki po EXP. Rok uporabnosti po prvem odpiranju vsebnika: 28 dni.
English: Do not use in dog and cats less than 6 weeks of age nor in cats of less than 2 kg.
Slovenian: Ne uporabite pri psih in mačkah, mlajših od 6 tednov, in mačkah, lažjih od 2 kg.
English: In vitro and in vivo studies demonstrated that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-1 (COX-1).
Slovenian: Raziskave in vitro ter in vivo so pokazale, da ima meloksikam močnejši zaviralni učinek na ciklooksigenazo 2 kot na ciklooksigenazo 1.
English: In horses, in rare cases a transient swelling at the injection site can occur but resolves without intervention.
Slovenian: Pri konjih se lahko v redkih primerih na mestu vboda pojavi prehodna oteklina, ki mine brez intervencije.
English: 3421 TV Oudewater The Netherlands
Slovenian: 3421 TV Oudewater Nizozemska
English: Locomotor disorders:
Slovenian: Lokomotorične motnje:
English: In case of inadequate relief of pain when used in the treatment of equine colic, careful re-evaluation of the diagnosis should be made as this could indicate the need for surgical intervention.
Slovenian: Pri nezadostnem olajšanju s koliko povezane bolečine pri konjih moramo diagnozo ponovno skrbno preveriti, ker lahko nezadosten odziv kaže na to, da je potreben kirurški poseg.
English: Dosage for each species
Slovenian: Odmerjanje za vsako živalsko vrsto
English: In case of overdose symptomatic treatment should be initiated.
Slovenian: Pri prevelikem odmerjanju uvedite simptomatsko zdravljenje.
English: These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Slovenian: Našteti neželeni škodljivi učinki se pretežno pojavijo v prvem tednu zdravljenja, so večinoma prehodni in po končanem zdravljenju minejo, vendar so lahko v zelo redkih primerih tudi resni ali smrtno nevarni.
English: These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Slovenian: Naštete neželeni učinki se pretežno pojavijo v prvem tednu zdravljenja, so večinoma prehodni in po končanem zdravljenju minejo, vendar so lahko v zelo redkih primerih tudi resni ali smrtno nevarni.
English: Cattle: Can be used during pregnancy.
Slovenian: Govedo: Lahko se uporablja v obdobju brejosti.
English: 4941 SJ Raamsdonksveer The Netherlands
Slovenian: 4941 SJ Raamsdonksveer Nizozemska
English: Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Slovenian: Ne uporabite v primerih preobčutljivosti na učinkovino ali na katero koli od pomožnih snovi.
English: Manufacturer responsible for the batch release: Produlab Pharma B.V.
Slovenian: Izdelovalec, odgovoren za sproščanje serij: Produlab Pharma B.V.
English: Approximately 75 % of the administered dose is eliminated via faeces and the remainder via urine in dogs.
Slovenian: Približno 75 % vnesenega odmerka se pri psih izloči z blatom, preostala količina pa z urinom.
English: Treatment of calves with Meloxidolor 20 minutes before dehorning reduces post-operative pain.
Slovenian: Zdravljenje telet z zdravilom Meloxidolor 20 minut pred odstranitvijo rogov zmanjša pooperativno bolečino.
English: Incompatibilities:
Slovenian: Inkompatibilnosti
English: Shelf-life after first opening the container:28 days.
Slovenian: Rok uporabnosti po prvem odpiranju vsebnika: 28 dni.
English: Name and address of the manufacturer responsible for batch release Produlab Pharma B.V.
Slovenian: Ime in naslov proizvajalca zdravila, odgovornega za sproščanje serij Produlab Pharma B.V.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP.
Slovenian: Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na zunanji ovojnini in viali za EXP.
English: The veterinary medicinal product should not be administered by pregnant women or women of childbearing potential as Meloxicam may be harmful to the foetus and unborn child.
Slovenian: Noseče ženske in ženske v rodni dobi naj tega zdravila za uporabo v veterinarski medicini ne dajejo, sa je lahko zdravilo Meloksikam škodljivo za plod ali nerojenega otroka.
English: Fax: +31 (0)348 565454
Slovenian: Faks: +31 (0)348 565454
English: Dogs, Cattle: Single subcutaneous or intravenous injection Cats: Single subcutaneous injection Pigs: Single intramuscular injection Read the package leaflet before use
Slovenian: Psi, govedo: enkratna subkutana ali intravenska injekcija Mačke: enkratna subkutana injekcija Prašiči: enkratna intramuskularna injekcija.
English: Dogs, cats, cattle (calves) and pigs
Slovenian: Psi, mačke, govedo (teleta) in prašiči
English: There is a linear relationship between the dose administered and plasma concentration observed in the therapeutic dose range in dogs and cats.
Slovenian: Med vnesenim odmerkom in koncentracijo v plazmi je pri terapevtskem razponu odmerkov pri psih in mačkah linearno razmerje.
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals: Accidental self-injection may give rise to pain.
Slovenian: Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo Nenamerno samoinjiciranje lahko povzroči bolečino.
English: In cattle and pigs, subcutaneous, intramuscular as well as intravenous administration is well tolerated; only a slight transient swelling at the injection site following subcutaneous administration was observed in less than 10 % of the cattle treated in clinical studies.
Slovenian: Govedo in prašiči podkožno, intramuskularno in intravensko dajanje dobro prenašajo; v kliničnih raziskavah so zasledili samo blago in prehodno oteklino na mestu podkožne injekcije, in sicer pri manj kot 10 % goveda.
English: Multi-pack of 12 x 100ml
Slovenian: Multi-paket 12 x 100 ml
English: Package (size)
Slovenian: Pakiranje (velikost)
English: TARGET SPECIES Dogs, cats, cattle (calves) and pigs
Slovenian: CILJNE ŽIVALSKE VRSTE Psi, mačke, govedo (teleta) in prašiči
English: Treatment of piglets with Meloxidolor before castration reduces post-operative pain.
Slovenian: Zdravljenje pujskov z zdravilom Meloxidolor pred kastracijo blaži postoperativno bolečino.